Brexanolone
Products Brexanolone was approved in the United States in 2019 in the form of an infusion product (Zulresso). Structure and properties Brexanolone (C21H34O2, Mr = 318.5 g/mol) corresponds to allopregnanolone, the major metabolite of the progestogen progesterone. Effects Brexanolone corresponds to the progesterone metabolite allopregnanolone, which peaks in the third trimester of pregnancy and whose … Brexanolone
